Inroduction: This study reports on our experience with transcatheter closure of perimembraneous ventricular septal defects (pm-VSDs) with Amplatzer duct occluder I (ADO I) and Amplatzer duct occluder II (ADO II) Methods: Transcatheter device implantation with ADO I and ADO II was attempted in 17 patients with pm-VSD between August 2014 to December 2015. We usually decided the appropriate type a...

Percutaneous intervention is preferred over reoperation for the treatment of iatrogenic membranous ventricular septal defects (VSDs). During the standard percutaneous procedure, an arterio-venous loop is used for occluder deployment, entailing the risk of device impingement on the prosthetic aortic valve, which may cause serious complications or even death. In this report, we describe a novel n...

BACKGROUND Percutaneous transcatheter closure of patent foramen ovale (PFO) in cryptogenic stroke is an alternative to medical therapy. There is still debate on different outcome for each currently available device. The impact of residual shunting after PFO-closure on recurrent arterial embolism is unknown. - AIMS (i) To evaluate the prevalence of residual interatrial shunting after device- c...

BACKGROUND Device closure of Secundum atrial septal defect (ASD) is an accepted mode of treatment in selected patients with a suitable defect. The major initial concern over the long-term outcome has been erosions and more recently development of aortic regurgitation. Objective was to assess the intermediate and long term outcome of patients with device closure of ASD with special reference to ...

Closure of residual ventricular septal defect with an occluder is traditionally performed by a percutaneous transcatheter approach under radiographic guidance. However, this procedure may be of limited use in cases with unusually shaped defects and in patients with low body weight. Here, we report minimally invasive surgical device closure of a 6 mm residual ventricular septal defect under tran...

We report the case of a 72-year-old woman diagnosed with ostium secundum atrial septal defect (OS-ASD) in an echocardiogram performed as part of the work-up for her high blood pressure. Over time, progressive dilation of the right ventricle was observed with progressive functional deterioration, indicating closure of the defect. Transesophageal echocardiography (TEE) confirmed an OS-ASD of 15×1...

Percutaneous left atrial appendage (LAA) closure has been recognised as an alternative therapy for stroke prevention in selected patients with non-valvular fibrillation (AF) who have difficulties long-term oral anticoagulation. Peri-device leaks (PDLs) are frequently diagnosed after LAA procedures, regardless of methods. PDL > 5mm is related further embolic events. Nevertheless, management seve...

A 39-year-old woman underwent uneventful percutaneous occlusion of an ostium secundum atrial septal defect (ASD) with a 22 mm Ultrasept ASD Occluder®. Transesophageal echocardiography (TEE) performed two years after implantation revealed a de novo residual left-to-right shunt through the correctly implanted device. Three-dimensional transesophageal echocardiography (3D TEE) further clarified th...

Transcatheter closure of patent ductus arteriosus with the Amplatzer duct occluder shows excellent results. However, there is a risk of device embolization after deployment. We report the case of a 33-year-old man in whom an embolized Amplatzer device was retrieved from the right pulmonary artery by a percutaneous method. We also review this uncommon severe complication and offer technical tips...